REMoDL-B clinical trial: results presented at ASH 2015
Targeted molecular signatures of DLBCL and upcoming CheckMate 647 trial for PCNSL and PTL
Panel discussion on large cell lymphomas: subtypes, patient selection and mutations
Andrew Zelenetz et al.
Negative-data clinical trials in lymphoma presented at ASH 2015
An overview of the current treatment landscape of non-Hodgkin lymphoma